Nancy Devlin : Citation Profile


Are you Nancy Devlin?

University of Melbourne (47% share)
University of Sheffield (47% share)
Office of Health Economics (6% share)

13

H index

17

i10 index

614

Citations

RESEARCH PRODUCTION:

56

Articles

51

Papers

4

Books

RESEARCH ACTIVITY:

   26 years (1994 - 2020). See details.
   Cites by year: 23
   Journals where Nancy Devlin has often published
   Relations with other researchers
   Recent citing documents: 42.    Total self citations: 63 (9.31 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pde347
   Updated: 2021-03-01    RAS profile: 2020-11-22    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Shah, Koonal (20)

Feng, Yan (11)

Hampson, Grace (6)

Cole, Amanda (5)

Parkin, David (3)

Zamora Talaya, Bernarda (3)

Cubi-Molla, Patricia (3)

Mott, David (3)

Shah, Kalim (2)

Brazier, John (2)

Garau, Martina (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with Nancy Devlin.

Is cited by:

Brouwer, Werner (18)

Brazier, John (17)

Attema, Arthur (13)

Tsuchiya, Aki (13)

Shah, Koonal (12)

Siciliani, Luigi (11)

Towse, Adrian (10)

Blankart, Katharina (9)

Hernandez Alava, Monica (8)

Claxton, Karl (8)

pudney, stephen (7)

Cites to:

Shah, Koonal (61)

Parkin, David (44)

Tsuchiya, Aki (37)

Feng, Yan (34)

Brazier, John (22)

Rice, Nigel (16)

Roberts, Jennifer (12)

Appleby, John (8)

Claxton, Karl (7)

Street, Andrew (7)

Shah, Kalim (6)

Main data


Where Nancy Devlin has published?


Journals with more than one article published# docs
Health Economics15
The European Journal of Health Economics11
PharmacoEconomics10
Health Policy6
Social Science & Medicine4
Applied Health Economics and Health Policy2
PharmacoEconomics - Open2

Working Papers Series with more than one paper published# docs
Research Papers / Office of Health Economics26
Working Papers / Department of Economics, City University London11
Consulting Reports / Office of Health Economics6
Working Papers / Centre for Health Economics, University of York5

Recent works citing Nancy Devlin (2021 and 2020)


YearTitle of citing document
2020A systematic review of child-focused outcomes and assessments of arts therapies delivered in primary mainstream schools. (2020). Powell, Joanne ; Karkou, Vicky ; Aithal, Supritha ; Moula, Zoe. In: Children and Youth Services Review. RePEc:eee:cysrev:v:112:y:2020:i:c:s0190740919313040.

Full description at Econpapers || Download paper

2020Living up to expectations: Experimental tests of subjective life expectancy as reference point in time trade-off and standard gamble. (2020). Brouwer, Werner ; Attema, Arthur ; Lipman, Stefan A. In: Journal of Health Economics. RePEc:eee:jhecon:v:71:y:2020:i:c:s0167629619302279.

Full description at Econpapers || Download paper

2020Multiple Criteria Decision Analysis for HTA across four EU Member States: Piloting the Advance Value Framework. (2020). Molina-Lopez, T ; Montibeller, G ; Linch, M ; Angelis, A ; Kanavos, P ; Espin, J ; Arickx, F ; Orzel, K ; Zawada, A. In: Social Science & Medicine. RePEc:eee:socmed:v:246:y:2020:i:c:s0277953619305908.

Full description at Econpapers || Download paper

2020Can healthcare choice be predicted using stated preference data?. (2020). Swait, Joffre ; Donkers, Bas ; Bliemer, Michiel ; de Bekker-Grob, E W ; Veldwijk, J ; Bliemer, M. C. J., . In: Social Science & Medicine. RePEc:eee:socmed:v:246:y:2020:i:c:s0277953619307312.

Full description at Econpapers || Download paper

2020Examining the transnational health preferences of a group of Eastern European migrants relative to a European host population using the EQ-5D-5L. (2020). O'Neill, Stephen ; Hobbins, Anna ; Barry, Luke ; Kelleher, Dan ; Doherty, Edel. In: Social Science & Medicine. RePEc:eee:socmed:v:246:y:2020:i:c:s0277953620300204.

Full description at Econpapers || Download paper

2020Health and wellbeing in Norway: Population norms and the social gradient. (2020). Lamu, Admassu Nadew ; Lindberg, Marie Hella ; Olsen, Jan Abel. In: Social Science & Medicine. RePEc:eee:socmed:v:259:y:2020:i:c:s0277953620303749.

Full description at Econpapers || Download paper

2020Understanding the composite dimensions of the EQ-5D: An experimental approach. (2020). Tsuchiya, Aki ; Mullett, Timothy L ; McDonald, Rebecca. In: Social Science & Medicine. RePEc:eee:socmed:v:265:y:2020:i:c:s0277953620305426.

Full description at Econpapers || Download paper

2020Complexity Stage Model of the Medical Device Development Based on Economic Evaluation—MedDee. (2020). Peter, Luka ; Mareova, Petra ; Kua, Kamil ; Klimova, Blanka ; Mohelska, Hana ; Augustnek, Martin ; Penhaker, Marek ; Ren, Luka ; Honegr, Jan. In: Sustainability. RePEc:gam:jsusta:v:12:y:2020:i:5:p:1755-:d:325509.

Full description at Econpapers || Download paper

2020Mass media coverage and vaccination uptake: evidence from the demand for meningococcal vaccinations in Hungary. (2020). Szabo-Morvai, Agnes ; Biro, Aniko. In: IEHAS Discussion Papers. RePEc:has:discpr:2018.

Full description at Econpapers || Download paper

2020Performance Management Strategy: Waiting Time in the English National Health Services. (2020). Cookson, Graham ; Elkomy, Shimaa. In: Public Organization Review. RePEc:kap:porgrv:v:20:y:2020:i:1:d:10.1007_s11115-018-0425-7.

Full description at Econpapers || Download paper

2020Elicitation and modelling of imprecise utility of health states. (2020). Golicki, Dominik ; Jakubczyk, Micha. In: Theory and Decision. RePEc:kap:theord:v:88:y:2020:i:1:d:10.1007_s11238-019-09707-6.

Full description at Econpapers || Download paper

2020Health-related quality of life among patients with type 2 diabetes mellitus in Eastern Province, Saudi Arabia: A cross-sectional study. (2020). Joseph, Royes ; Alshayban, Dhfer. In: PLOS ONE. RePEc:plo:pone00:0227573.

Full description at Econpapers || Download paper

2020A two-step procedure to generate utilities for the Infant health-related Quality of life Instrument (IQI). (2020). , Paul ; Vermeulen, Karin M ; Dainelli, Livia ; Detzel, Patrick ; Jabrayilov, Ruslan. In: PLOS ONE. RePEc:plo:pone00:0230852.

Full description at Econpapers || Download paper

2020Factors Influencing the Cost-Effectiveness Outcomes of HPV Vaccination and Screening Interventions in Low-to-Middle-Income Countries (LMICs): A Systematic Review. (2020). Ridyard, Colin H ; Okeah, Bernard O. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:18:y:2020:i:5:d:10.1007_s40258-020-00576-7.

Full description at Econpapers || Download paper

2020A Systematic Review of the Association Between Hospital Cost/price and the Quality of Care. (2020). Schreyogg, Jonas ; Winter, Vera ; Jamalabadi, Sara. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:18:y:2020:i:5:d:10.1007_s40258-020-00577-6.

Full description at Econpapers || Download paper

2020Economic evaluation of meningococcal vaccines: considerations for the future. (2020). Shah, Koonal ; Lorgelly, Paula ; York, Laura ; Landa, Paolo ; Wright, Claire ; Bloom, David E ; Glennie, Linda ; Postma, Maarten J ; Smith, Vinny ; Levy, Pierre ; HERNaNDEZ-VILLAFUERTE, KARLA ; Al-Janabi, Hareth ; Christensen, Hannah ; Towse, Adrian K ; Diez-Domingo, Javier ; Salisbury, David M ; Farkouh, Raymond ; Damm, Oliver . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:2:d:10.1007_s10198-019-01129-z.

Full description at Econpapers || Download 2020

Cost-effectiveness analysis of the Neuropad device as a screening tool for early diabetic peripheral neuropathy. (2020). Rodriguez-Sanchez, B ; Sinclair, A J ; Pea-Longobardo, L M. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:3:d:10.1007_s10198-019-01134-2.

Full description at Econpapers || Download paper

2020A vision ‘bolt-on’ increases the responsiveness of EQ-5D: preliminary evidence from a study of cataract surgery. (2020). Gandhi, Mihir ; Luo, Nan ; Janssen, Mathieu F ; Tan, Rachel Lee-Yin ; Wei, Yvonne Chung-Hsi ; Wong, Chee Wai ; Teo, Kelvin ; Ang, Marcus. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:4:d:10.1007_s10198-019-01156-w.

Full description at Econpapers || Download paper

2020Transforming discrete choice experiment latent scale values for EQ-5D-3L using the visual analogue scale. (2020). Wright, Penny ; Kind, Paul ; Meads, David ; Odwyer, John. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:5:d:10.1007_s10198-020-01173-0.

Full description at Econpapers || Download paper

2020Does linear equating improve prediction in mapping? Crosswalking MacNew onto EQ-5D-5L value sets. (2020). Lamu, Admassu N. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:6:d:10.1007_s10198-020-01183-y.

Full description at Econpapers || Download paper

2020Discrete choice experiments to generate utility values for multi-attribute utility instruments: a systematic review of methods. (2020). Bahrampour, Mina ; Downes, Martin ; Scuffham, Paul A ; Norman, Richard ; Byrnes, Joshua. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:7:d:10.1007_s10198-020-01189-6.

Full description at Econpapers || Download paper

2020Measuring intangible cost-of-morbidity due to substance dependence: implications of using alternative preference-based instruments. (2020). Casal, Bruno ; Rivera, Berta ; Rodriguez-Miguez, Eva . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:7:d:10.1007_s10198-020-01196-7.

Full description at Econpapers || Download paper

2020Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines. (2020). Reenen, Mandy ; Herdman, Michael ; Slaap, Bernhard ; Kennedy-Martin, Matthew ; Boye, Kristina S ; Busschbach, Jan ; Greiner, Wolfgang. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:8:d:10.1007_s10198-020-01195-8.

Full description at Econpapers || Download paper

2020EQ-5D-5L Bulgarian population norms. (2020). Golicki, Dominik ; Vekov, Toni ; Djambazov, Slaveyko ; Encheva, Marta. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:8:d:10.1007_s10198-020-01225-5.

Full description at Econpapers || Download paper

2020HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies. (2020). Shah, Koonal ; Graf von der Schulenburg, Johann ; Shen, Jie ; Durand-Zaleski, Isabelle ; Ratcliffe, Mark ; Coyle, Doug ; Pemberton-Whiteley, Zack ; Palmer, Stephen ; Moutie, Anne-Sophie ; Meunier, Aurelie ; Longworth, Louise ; Greiner, Wolfgang ; Zhao, Kun ; Garrison, Louis ; Sproule, Doug ; Farrington, Jasmine. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:9:d:10.1007_s10198-020-01212-w.

Full description at Econpapers || Download 2020

Multiplicative modelling of EQ-5D-3L TTO and VAS values. (2020). Thakumar, Annushiah Vasan ; Shafie, Asrul Akmal. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:9:d:10.1007_s10198-020-01233-5.

Full description at Econpapers || Download paper

2021Increasing respondent engagement in composite time trade-off tasks by imposing three minimum trade-offs to improve data quality. (2021). Kohlmann, Thomas ; Jiang, Ruixuan ; Pickard, Simon A ; Walton, Surrey ; shaw, james ; Muhlbacher, Axel ; Lee, Todd A. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:22:y:2021:i:1:d:10.1007_s10198-020-01224-6.

Full description at Econpapers || Download paper

2020The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: evidence from an online experiment. (2020). Boes, Stefan ; Wettstein, Dominik J. In: Health Economics Review. RePEc:spr:hecrev:v:10:y:2020:i:1:d:10.1186_s13561-020-00267-y.

Full description at Econpapers || Download paper

2020A Picture is Worth a Thousand Words: The Role of Survey Training Materials in Stated-Preference Studies. (2020). Vass, Caroline M ; Payne, Katherine ; Stichele, Geert ; Davison, Niall J. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:13:y:2020:i:2:d:10.1007_s40271-019-00391-w.

Full description at Econpapers || Download paper

2021Giving a Voice to Marginalised Groups for Health Care Decision Making. (2021). Watson, JO ; Ratcliffe, Julie ; Ong, Jason J ; Howard, Kirsten ; Devlin, Nancy ; de Abreu, Richard ; Huynh, Elisabeth ; Willing, Esther. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:14:y:2021:i:1:d:10.1007_s40271-020-00456-1.

Full description at Econpapers || Download paper

2020Informing a Cost-Effectiveness Threshold for Health Technology Assessment in China: A Marginal Productivity Approach. (2020). Lomas, James ; Gu, Yuanyuan ; Wang, Haiyin ; Ochalek, Jessica ; Jin, Chunlin ; Cutler, Henry. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:12:d:10.1007_s40273-020-00954-y.

Full description at Econpapers || Download paper

2020After 20 Years of Using Economic Evaluation, Should NICE be Considered a Methods Innovator?. (2020). Palmer, Stephen ; Sculpher, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:3:d:10.1007_s40273-019-00882-6.

Full description at Econpapers || Download paper

2020A French Value Set for the EQ-5D-5L. (2020). Andrade, Luiz Flavio ; Pouvourville, Gerard ; Oppe, Mark ; Ramos, Juan Manuel ; Ludwig, Kristina. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:4:d:10.1007_s40273-019-00876-4.

Full description at Econpapers || Download paper

2020Feasibility, Validity and Differences in Adolescent and Adult EQ-5D-Y Health State Valuation in Australia and Spain: An Application of Best–Worst Scaling. (2020). Dalziel, Kim ; Rivero-Arias, Oliver ; Norman, Richard ; Gorostiza, Inigo ; Garcia-Lorenzo, Borja ; Catchpool, Max. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:5:d:10.1007_s40273-020-00884-9.

Full description at Econpapers || Download paper

2020Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States. (2020). Gerdtham, Ulf-G. ; Leidl, Reiner ; Ulf-G. Gerdtham, ; Ulf- G. Gerdtham, ; Teni, Fitsum Sebsibe ; Burstrom, Kristina ; Henriksson, Martin ; Rolfson, Ola ; Helgesson, Gert. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:8:d:10.1007_s40273-020-00905-7.

Full description at Econpapers || Download paper

2021Modifying NICE’s Approach to Equity Weighting. (2021). McCabe, Christopher ; Paulden, Mike. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:2:d:10.1007_s40273-020-00988-2.

Full description at Econpapers || Download paper

2021NICE’s Discounting Review: Clear Thinking on Rational Revision Meets Obstacle of Industrial Interests. (2021). Paulden, Mike ; Omahony, James F ; McCabe, Chris . In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:2:d:10.1007_s40273-020-00990-8.

Full description at Econpapers || Download paper

2020Is Protocolised Weaning that Includes Early Extubation Onto Non-Invasive Ventilation More Cost Effective Than Protocolised Weaning Without Non-Invasive Ventilation? Findings from the Breathe Study. (2020). Maredza, Mandy ; Khan, Iftekhar ; Petrou, Stavros ; Perkins, Gavin D ; Gates, Simon ; Couper, Keith ; Lamb, Sarah E ; Lall, Ranjit ; Mistry, Dipesh ; Dritsaki, Melina. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:4:d:10.1007_s41669-020-00210-1.

Full description at Econpapers || Download 2020

The efficiency of hospitals: platform for sustainable health care system. (2020). Kocisova, Kristina ; Gavurova, Beata. In: Entrepreneurship and Sustainability Issues. RePEc:ssi:jouesi:v:8:y:2020:i:2:p:133-146.

Full description at Econpapers || Download paper

2020Tolerance intervals for autoregressive models, with an application to hospital waiting lists. (2020). Cheng, Kedai ; Young, Derek S. In: Applied Stochastic Models in Business and Industry. RePEc:wly:apsmbi:v:36:y:2020:i:2:p:268-282.

Full description at Econpapers || Download paper

2020What is it going to be, TTO or SG? A direct test of the validity of health state valuation. (2020). Attema, Arthur ; Lipman, Stefan A. In: Health Economics. RePEc:wly:hlthec:v:29:y:2020:i:11:p:1475-1481.

Full description at Econpapers || Download paper

2021Social tariffs and democratic choice—Do population?based health state values reflect the will of the people?. (2021). Schneider, Paul Peter. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:1:p:104-112.

Full description at Econpapers || Download paper

Works by Nancy Devlin:


YearTitleTypeCited
1995Comment: Financing New Zealand’s Tertiary Education: How Much Subsidy? In: Agenda - A Journal of Policy Analysis and Reform.
[Full Text][Citation analysis]
article0
1994The effects of denturism: New Zealand dentists response to competition In: American Journal of Public Health.
[Citation analysis]
article0
2000The health state preferences and logistical inconsistencies of New Zealanders: a tale of two tariffs In: Working Papers.
[Full Text][Citation analysis]
paper1
2011Truly inefficient or providing better quality of care? Analysing the relationship between riskadjusted hospital costs and patients’ health outcomes In: Working Papers.
[Full Text][Citation analysis]
paper20
2013TRULY INEFFICIENT OR PROVIDING BETTER QUALITY OF CARE? ANALYSING THE RELATIONSHIP BETWEEN RISK‐ADJUSTED HOSPITAL COSTS AND PATIENTS HEALTH OUTCOMES.(2013) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 20
article
2012Analysing Hospital Variation in Health Outcome at the Level of EQ-5D Dimensions In: Working Papers.
[Full Text][Citation analysis]
paper1
2013Methods for the estimation of the NICE cost effectiveness threshold In: Working Papers.
[Full Text][Citation analysis]
paper42
2013The influence of cost-effectiveness and other factors on NICE decisions In: Working Papers.
[Full Text][Citation analysis]
paper30
2013The Influence of Cost-effectiveness and Other Factors on NICE Decisions.(2013) In: Research Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 30
paper
2015The Influence of Cost‐Effectiveness and Other Factors on Nice Decisions.(2015) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 30
article
2003Does NICE have a cost effectiveness threshold and what other factors influence its decisions? A discrete choice analysis In: Working Papers.
[Full Text][Citation analysis]
paper3
2004Is there a case for using Visual Analogue Scale valuations in Cost-Utility Analysis? In: Working Papers.
[Full Text][Citation analysis]
paper25
2006Is there a case for using visual analogue scale valuations in cost‐utility analysis?.(2006) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 25
article
2004A theoretical framework for TTO valuations and a taxonomy of TTO approaches: results from a pilot study In: Working Papers.
[Full Text][Citation analysis]
paper0
2005Understanding individuals’ decisions about vaccination: a comparison between Expected Utility and Regret Theory models In: Working Papers.
[Full Text][Citation analysis]
paper0
2006The impact of government targets on waiting times for elective surgery: new insights from time-to-event analysis In: Working Papers.
[Full Text][Citation analysis]
paper0
2008A note on the nature of utility in time and health and implications for cost utility analysis In: Working Papers.
[Full Text][Citation analysis]
paper3
2009A note on the nature of utility in time and health and implications for cost utility analysis.(2009) In: Social Science & Medicine.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 3
article
2008Statistical analysis of EQ-5D profiles: does the use of value sets bias inference? In: Working Papers.
[Full Text][Citation analysis]
paper3
2009Using the EQ-5D as a performance measurement tool in the NHS In: Working Papers.
[Full Text][Citation analysis]
paper2
2009Does the value of quality of life depend on duration? In: Working Papers.
[Full Text][Citation analysis]
paper2
2009A uniform Time Trade Off method for states better and worse than dead: feasibility study of the ‘lead time’ approach In: Working Papers.
[Full Text][Citation analysis]
paper25
2011A uniform time trade off method for states better and worse than dead: feasibility study of the ‘lead time’ approach.(2011) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 25
article
2013A Study of the Relationship Between Health and Subjective Well-being in Parkinson’s Disease Patients In: Working Papers.
[Full Text][Citation analysis]
paper3
2013A Study of the Relationship Between Health and Subjective Well-being in Parkinsons Disease Patients.(2013) In: Research Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 3
paper
2015Local health care expenditure plans and their opportunity costs In: Health Policy.
[Full Text][Citation analysis]
article3
2020Do people with private health insurance attach a higher value to health than those without insurance? Results from an EQ-5D-5 L valuation study in Ireland In: Health Policy.
[Full Text][Citation analysis]
article0
2020The impact of price transparency on consumers and providers: A scoping review In: Health Policy.
[Full Text][Citation analysis]
article0
1996The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand In: Health Policy.
[Full Text][Citation analysis]
article6
2006Yes, No or Yes, but? Multinomial modelling of NICE decision-making In: Health Policy.
[Full Text][Citation analysis]
article6
2009Searching for cost effectiveness thresholds in the NHS In: Health Policy.
[Full Text][Citation analysis]
article18
2020A new tool for creating personal and social EQ-5D-5L value sets, including valuing ‘dead’ In: Social Science & Medicine.
[Full Text][Citation analysis]
article0
1999The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule In: Social Science & Medicine.
[Full Text][Citation analysis]
article2
2005Continuity through change: The rhetoric and reality of health reform in New Zealand In: Social Science & Medicine.
[Full Text][Citation analysis]
article9
2009Identifying the impact of government targets on waiting times in the NHS In: Health Care Management Science.
[Full Text][Citation analysis]
article33
2000Allocating Vote: Health — ‘Needs Assessment’ and an Economics-Based Approach In: Treasury Working Paper Series.
[Full Text][Citation analysis]
paper0
2016New Age Decision Making in HTA: Is It Applicable in Asia? In: Briefings.
[Full Text][Citation analysis]
paper0
2012Time Trends in NICE HTA Decisions In: Consulting Reports.
[Full Text][Citation analysis]
paper0
2011The Evolution of HTA in Emerging Markets Health Care Systems: Analysis to Support a Policy Response In: Consulting Reports.
[Full Text][Citation analysis]
paper6
2015Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices? In: Consulting Reports.
[Full Text][Citation analysis]
paper3
2016Shaping the Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making In: Consulting Reports.
[Full Text][Citation analysis]
paper2
2018Quality of Life in Long-term Cancer Survivors: Implications for Future Health Technology Assessments in Oncology In: Consulting Reports.
[Full Text][Citation analysis]
paper0
2019Public Preferences for Health Gains and Cures: A Discrete Choice Experiment In: Consulting Reports.
[Full Text][Citation analysis]
paper1
2011Incorporating Multiple Criteria in HTA: Methods and Processes In: Monographs.
[Full Text][Citation analysis]
book21
2010Getting the Most out of PROMs: Putting Health Outcomes at the Heart of NHS Decision-Making In: Monographs.
[Full Text][Citation analysis]
book7
2002Cost-Effectiveness Thresholds: Economic and ethical issues In: Monographs.
[Full Text][Citation analysis]
book10
2004How Much Should We Spend on the NHS? In: Monographs.
[Full Text][Citation analysis]
book1
2013Searching for Cost-effectiveness Thresholds in NHS Scotland In: Research Papers.
[Full Text][Citation analysis]
paper0
2012Understanding Social Preferences Regarding the Prioritisation of Treatments Addressing Unmet Need and Severity In: Research Papers.
[Full Text][Citation analysis]
paper4
2012Assessing the Performance of the EQ-VAS in the NHS PROMs Programme In: Research Papers.
[Full Text][Citation analysis]
paper2
2011Operationalising Value Based Pricing of Medicines: A Taxonomy of Approaches In: Research Papers.
[Full Text][Citation analysis]
paper1
2011Is the Aim of the Health Care System to Maximise QALYs? An Investigation of In: Research Papers.
[Full Text][Citation analysis]
paper0
2010A Comparison of Alternative Variants of the Lead and Lag Time TTO In: Research Papers.
[Full Text][Citation analysis]
paper14
2013A COMPARISON OF ALTERNATIVE VARIANTS OF THE LEAD AND LAG TIME TTO.(2013) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 14
article
2014Opportunity Costs of Implementing NICE Decisions in NHS Wales In: Research Papers.
[Full Text][Citation analysis]
paper1
2014What Determines the Shape of an EQ-5D Index Distribution? In: Research Papers.
[Full Text][Citation analysis]
paper3
2015An Investigation of the Feasibility and Cultural Appropriateness of Stated Preference Methods to Generate EQ-5D-5L Values in the United Arab Emirates In: Research Papers.
[Full Text][Citation analysis]
paper0
2016Valuing Health-Related Quality of Life: An EQ-5D-5L Value Set for England In: Research Papers.
[Full Text][Citation analysis]
paper51
2018Valuing health‐related quality of life: An EQ‐5D‐5L value set for England.(2018) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 51
article
2016New Methods for Modelling EQ-5D-5L Value Sets: An Application to English Data In: Research Papers.
[Full Text][Citation analysis]
paper15
2018New methods for modelling EQ‐5D‐5L value sets: An application to English data.(2018) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 15
article
2016A Review of NICE Methods Across Health Technology Assessment Programmes: Differences, Justifications and Implications In: Research Papers.
[Full Text][Citation analysis]
paper3
2016The Distribution of the EQ-5D-5L Index in Patient Populations In: Research Papers.
[Full Text][Citation analysis]
paper0
2016Applying a Multi-criteria Decision Analysis (MCDA) Approach to Elicit Stakeholders Preferences in Italy. The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL) In: Research Papers.
[Full Text][Citation analysis]
paper0
2018Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL).(2018) In: PharmacoEconomics - Open.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 0
article
2016An Analysis of NICE Technology Appraisal Decisions Recommended in Line with Clinical Practice In: Research Papers.
[Full Text][Citation analysis]
paper0
2017What is the Normative Basis for Selecting the Measure of Average Preferences for Use in Social Choices? In: Research Papers.
[Full Text][Citation analysis]
paper1
2017Comparing the UK EQ-5D-3L and the English EQ-5D-5L Value Sets In: Research Papers.
[Full Text][Citation analysis]
paper5
2018Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets.(2018) In: PharmacoEconomics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 5
article
2017Age and Utilities: Issues for HTA In: Research Papers.
[Full Text][Citation analysis]
paper0
2017A New Valuation Method: Directly Eliciting Personal Utility Functions In: Research Papers.
[Full Text][Citation analysis]
paper1
2018New Methods for Analysing the Distribution of EQ-5D Observations In: Research Papers.
[Full Text][Citation analysis]
paper0
2019Can We Really Compare and Aggregate PRO Data Between People and Settings? Implications for Multi-Country Clinical Trials and HTA In: Research Papers.
[Full Text][Citation analysis]
paper1
2019Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England In: Research Papers.
[Full Text][Citation analysis]
paper0
2019Valuing EQ-5D-Y Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ? In: Research Papers.
[Full Text][Citation analysis]
paper0
2020Anchoring Latent Scale Values for the EQ-5D-Y at 0 = Dead In: Research Papers.
[Full Text][Citation analysis]
paper0
2013The Effect of Perceived Risks on the Demand for Vaccination: Results from a Discrete Choice Experiment In: PLOS ONE.
[Full Text][Citation analysis]
article6
2012Time to tweak the TTO. But how? In: MPRA Paper.
[Full Text][Citation analysis]
paper0
2017EQ-5D and the EuroQol Group: Past, Present and Future In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article11
2017A Review of NICE Methods and Processes Across Health Technology Assessment Programmes: Why the Differences and What is the Impact? In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article3
2013The development of new research methods for the valuation of EQ-5D-5L In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article8
2013The effects of lead time and visual aids in TTO valuation: a study of the EQ-VT framework In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article2
2013Lead versus lag-time trade-off variants: does it make any difference? In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article1
2013Time to tweak the TTO: results from a comparison of alternative specifications of the TTO In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article1
2013One-to-one versus group setting for conducting computer-assisted TTO studies: findings from pilot studies in England and the Netherlands In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article1
2017Head-to-head comparison of health-state values derived by a probabilistic choice model and scores on a visual analogue scale In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article1
2018Valuing EQ-5D-5L health states ‘in context’ using a discrete choice experiment In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article2
2019Impact of mapped EQ-5D utilities on cost-effectiveness analysis: in the case of dialysis treatments In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2019A new method for valuing health: directly eliciting personal utility functions In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article4
2020An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y values In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2005A ‘new and improved’ EQ-5D valuation questionnaire? In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article2
2017Assessing Preference-Based Outcome Measures for Overactive Bladder: An Evaluation of Patient-Reported Outcome Data from the BESIDE Clinical Trial In: The Patient: Patient-Centered Outcomes Research.
[Full Text][Citation analysis]
article0
2010An Analysis of NICE’s ‘Restricted’ (or ‘Optimized’) Decisions In: PharmacoEconomics.
[Full Text][Citation analysis]
article2
2013Operationalizing Value-Based Pricing of Medicines In: PharmacoEconomics.
[Full Text][Citation analysis]
article10
2015A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE) In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
2018Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
20183L, 5L, What the L? A NICE Conundrum In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
2018Correction to: Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
2018Correction to: 3L, 5L, What the L? A NICE Conundrum In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
2020Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going? In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
2020International Valuation Protocol for the EQ-5D-Y-3L In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2019All Male Panels and Other Diversity Considerations for ISPOR In: PharmacoEconomics - Open.
[Full Text][Citation analysis]
article0
2001Health care spending and economic output: Granger causality In: Applied Economics Letters.
[Full Text][Citation analysis]
article41
2002The Purchasing of Health Care by Primary Care Organisations. An evaluation and Guide to Future Policy, by N. Mays, S. Wyke, G. Malbon, N. Goodwin. Open University Press, Buckingham and Philadelphia, 2 In: Health Economics.
[Full Text][Citation analysis]
article0
2003Logical inconsistencies in survey respondents health state valuations ‐ a methodological challenge for estimating social tariffs In: Health Economics.
[Full Text][Citation analysis]
article11
2004Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysis In: Health Economics.
[Full Text][Citation analysis]
article99
2004Getting Health Economics into Practice, Edited by David Kernick. Radcliffe Medical Press, Oxford, 2002. No. of pages: 358. ISBN 1‐85775‐575‐8 In: Health Economics.
[Full Text][Citation analysis]
article0
2006A theoretical framework for TTO valuations of health In: Health Economics.
[Full Text][Citation analysis]
article4
2007‘Is there a case for using visual analogue scale valuations in CUA? Yes there is a case, but what does it add to ordinal data?’ a rejoinder In: Health Economics.
[Full Text][Citation analysis]
article0
2010Patient‐reported outcome measures in the NHS: new methods for analysing and reporting EQ‐5D data In: Health Economics.
[Full Text][Citation analysis]
article8
2015INTER‐PROVIDER COMPARISON OF PATIENT‐REPORTED OUTCOMES: DEVELOPING AN ADJUSTMENT TO ACCOUNT FOR DIFFERENCES IN PATIENT CASE MIX In: Health Economics.
[Full Text][Citation analysis]
article1

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated November, 2 2021. Contact: CitEc Team